JENNIFER MCMANUS: Open Payments
NPI 1689919961 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 41 payments from 15 companies in 2025. Trend: 2023 $1,163 · 2024 $1,213 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 15 | $222 |
| Novo Nordisk Inc | 3 | $84 |
| Lilly USA, LLC | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| ABBVIE INC. | 3 | $67 |
| Orexo US, Inc. | 3 | $60 |
| Amgen Inc. | 2 | $45 |
| PFIZER INC. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: SUBLOCADE, MOUNJARO, AIRSUPRA, Zubsolv, Wegovy, REPATHA, NURTEC ODT, TRINTELLIX.
Industry payments across MD — which companies pay providers there.
